Aspen Park Pharmaceuticals Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Aspen Park Pharmaceuticals Inc.
Tech Transfer Deals, November 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced September through October 2015.
Start-Up Quarterly Statistics, Q4 2014
In Q4 2014 start-ups raised $1.5 billion, a new record. Several companies penned alliances with tech transfer entities; eight start-ups were acquired.
Emergings In Brief, January 2015
Snapshots of these recently formed companies: Aspen Park Pharmaceuticals, CeMeT, Enlitic, and TC BioPharm.
Out Of The Blocks, January 2015
Snapshots of these recently formed companies: Aspen Park Pharmaceuticals, CeMeT, Enlitic, Prima-Temp, and TC BioPharm.
- Drug Delivery
- OTC, Consumer
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.